The new corona virus SARS-CoV-2 has been raging since January 2020, spreading at an unprecedented pace, exhibiting insidious properties and puzzling experts. SCHURTER has taken this fact into account and has ramped up the production of its medical products.
Thanks to decades of expertise in manufacturing as a supplier of medical technology, SCHURTER was able to avert the lockdown of many of its production facilities. Pandemic and system-relevant plants were closed in very few countries.
SCHURTER took advantage of this situation and decided to drastically increase its capacities in favour of the production of components and input systems for medical technology.
Entitle is a pioneering privilege management solution that discovers, manages, and automates just-in-time (JIT) access and modern identity governance and…
Available freely to Samtec customers under NDA, SIBORG (Signal Integrity Breakout Region Guru) works with Ansys HFSS 3D Layout to…
Entire NR1 system purpose-built for a more affordable AI infrastructure allowing for faster deployment; furthering AI’s reach into more parts…
Following rapid growth in its customer base to over 400, funding will fuel further AI development and create a hybrid…
The addition of EA’s high-efficiency regenerative power supplies greatly expands Tektronix’s trusted offering Tektronix, Inc, a leading provider in test…
Melexis reveals its groundbreaking Induxis® switch, the MLX92442. Contactless, magnet-free, and strayfield immune, this monolithic solution directly detects conductive targets.…